(Q34790197)

4 August 2017

1 reference

title

Residual symptoms in depression an emerging therapeutic concept (English)

1 reference

4 August 2017

1

Nicoletta Sonino

1 reference

4 August 2017

Giovanni A Fava

2

1 reference

4 August 2017

publication date

1 May 2002

1 reference

Progress in Neuro-Psychopharmacology & Biological Psychiatry

4 August 2017

published in

1 reference

4 August 2017

volume

26

1 reference

4 August 2017

issue

4

1 reference

4 August 2017

page(s)

763-770

1 reference

Prevalence and clinical correlates of residual depressive symptoms in bipolar II disorder

4 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Patterns of ACTH response to oCRH in Cushing's disease: correlation with histological/immunocytochemical findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

The diagnosis of Cushing's syndrome: atypical presentations and laboratory shortcomings

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

1 reference

7 January 2021

Loss of Antidepressant Efficacy During Maintenance Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Cushing's syndrome: a psychiatric study of 29 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Serotonin and dopamine receptors in the rat pituitary gland: autoradiographic identification, characterization, and localization

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Serotonin and the regulation of hypothalamic-pituitary-adrenal axis function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Psychopathology in patients with endogenous Cushing's syndrome: ‘atypical’ or melancholic features

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

The longitudinal course of psychopathology in Cushing's syndrome after correction of hypercortisolism.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Subclinical symptoms in mood disorders: pathophysiological and therapeutic implications

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Cognitive-behavioral management of patients with bipolar disorder who relapsed while on lithium prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Serotonin-induced changes in membrane potential and cytosolic free calcium in a clonal pituitary cell line (AtT-20) of cultured mouse corticotropes

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Serotonin receptors involved in regulation of pituitary-adrenocortical function in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Role of 5-HT in stress, anxiety, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Diagnostic categorization of psychiatric disturbance in Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Stress, hypercortisolism and corticosteroid receptors in depression: implications for therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Phenomenology and family history of affective disorder in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Adult brain neurogenesis and psychiatry: a novel theory of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Psychiatric aspects of Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

A prospective study of psychiatric and psychological aspects of Cushing's syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Physiopathology of Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Cyproheptadine-Induced Remission of Cushing's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Molecular modeling of serotonin, ketanserin, ritanserin and their 5-HT2C receptor interactions

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Relapse prevention by means of paroxetine in ECT-treated patients with major depression: a comparison with imipramine and placebo in medium-term continuation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Serotonergic regulation of adrenocortical function

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Psychiatric phenomenology in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

The cellular neurobiology of depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Steroids and depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Cortisol levels predict cognitive impairment induced by electroconvulsive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Glucocorticoid receptors in major depression: relevance to pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Drug-induced depression

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Continuation pharmacotherapy in the prevention of relapse following electroconvulsive therapy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Glucocorticoids and hippocampal atrophy in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Effects of ritanserin on the behavioral, neuroendocrine, and cardiovascular responses to meta-chlorophenylpiperazine in healthy human subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

The use of ketoconazole as an inhibitor of steroid production

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Medical therapy for Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Serotonin, Cushing's disease, and depression.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Psychiatric disorders associated with Cushing's syndrome. Epidemiology, pathophysiology and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

A role for life events in the pathogenesis of Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Clinical correlates of major depression in Cushing's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

A clinical index for rating severity in Cushing's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Effect of the serotonin antagonists ritanserin and ketanserin in Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Decrease in cortisol reverses human hippocampal atrophy following treatment of Cushing's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Effects of ritanserin, a specific serotonin-S2 receptor antagonist, on the release of anterior pituitary hormones during insulin-induced hypoglycemia in normal humans

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Faulty cortisol/serotonin interplay. Psychopathological and biological characterisation of a new, hypothetical depression subtype (SeCA depression)

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Anxiety/aggression--driven depression. A paradigm of functionalization and verticalization of psychiatric diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

Enhanced corticotropin response to corticotropin-releasing hormone as a predictor of mania in euthymic bipolar patients

1 reference

https://api.crossref.org/works/10.1016%2FS0278-5846%2802%2900200-2

7 January 2021

10.1016/S0278-5846(02)00200-2

Identifiers

DOI

1 reference

4 August 2017

1 reference